We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Idox Plc | LSE:IDOX | London | Ordinary Share | GB0002998192 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.20 | 0.32% | 63.60 | 63.00 | 63.60 | 63.60 | 62.00 | 62.20 | 74,237 | 16:29:55 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Computer Related Svcs, Nec | 73.28M | 5.58M | 0.0121 | 52.56 | 291.76M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/8/2024 07:57 | 12/02/2024 "Meanwhile shareholders here have seen the share price do absolutely nothing for the past three years." In the past three years, the dividend has doubled. Personally I rather have a static share price and a rising dividend than a volatile share price and an uncertain dividend. | trcml | |
12/6/2024 13:23 | Idox (IDOX) Half Year results presentation - June 2024 Idox CEO, David Meaden and CFO, Anoop Kang present the group’s half-year results for the six months ended 30 April 2024, followed by Q&A. Watch the video here: Or listen to the podcast here: | tomps2 | |
11/6/2024 11:01 | A pretty unexciting update today. Looks like there's not much organic growth going on, all from acquisitions. I'm sure the board will reward themselves with some nice options soon though. | gargoyle2 | |
22/5/2024 20:41 | Good TU taking the wind out of the results in 3 weeks. We are pleased to report that the Group has delivered strong growth during the first six months of the year, generating revenue of c.£43m, representing year-on-year growth of over 20% and an increase in adjusted EBITDA1 to over £13m, in line with management expectations. The Group recorded a good order intake during the period of c.£54m providing increasing levels of recurring revenue visibility for the remainder of FY24 and into FY25. The Group continued to generate strong cash flow during the period and ended the half with a net debt2 position of c.£6.6m compared to a net debt position of £14.7m as at 31 October 2023. | wad collector | |
28/3/2024 23:58 | More conditional share awards made today, although some of the performance criteria are laughable. The revenue element starts to vest of the revenue for the 2026 financial year hits £95.28 million -- way less than the £99 million that analysts are predicting. The adjusted EPS element starts to vest at 2.95p for 2026 -- again, analysts are already estimating 3.14p. Hardly stellar growth from the 2.62p EPS achieved in 2023. Maybe Meaden and Kang will dip their hands into their own pockets and buy some before 2026. I won't hold my breath for that. | gargoyle2 | |
22/3/2024 19:45 | More free share options exercised and shares sold... Are the directors ever going to actually buy any shares? | gargoyle2 | |
08/3/2024 07:12 | Another 600k free share options exercised by Meaden -- of course selling about half of them, so that he doesn't have to dip his hands into his pockets for any tax. Now holds 1.4 million shares and I struggle to remember him actually buying any himself. With a share price that's gone nowhere for 3 years, looks to me like it's just rewarding failure. | gargoyle2 | |
12/2/2024 14:44 | A blast from the past, a pretty stale business now days. | clocktower | |
12/2/2024 14:22 | In fact, when are Meadon and Kang going to put their own money into this company? No share purchases for years. Kang has been CFO for 2 years now and is still just relying on free share options. Hasn't bought any shares himself despite his £280k plus comp package. | gargoyle2 | |
12/2/2024 09:57 | I'm a holder here, but they are taking the mick with the constant share issues under the LTIP, aren't they? 420k shares this month (£265k onto the market cap for nothing), 330k shares last month. Seems to me the company is being run for teh benefit of the employees, not the external shareholders. Look how many options Meaden and Kang were granted back in October, with some pretty undemanding performance criteria. Meanwhile shareholders here have seen the share price do absolutely nothing for the past three years. | gargoyle2 | |
26/1/2024 16:45 | Idox (IDOX) Full Year 2023 results presentation - January 24 Idox CEO, David Meaden and CFO, Anoop Kang present full year results for the period ended 31 October 23, followed by Q&A Watch the video here: Or listen to the podcast here: | tomps2 | |
12/12/2023 10:18 | Pleased to read the recent year-end trading update, with increases in top line growth and recurring revenue, adjusted EBITDA (& hope PBT is also...). The Group delivered a record order intake of over £82m in FY23, an increase of c.11% on the prior year, reflecting our high-quality customer base and strong market positions. The Board expects to report (subject to external audit) revenue and profit in line with expectations; revenue is expected to be up c.11% to c.£73m, with recurring revenue up c.8% over the period to c.£44m, delivering a c.9% increase in full year adjusted EBITDA to c.£24.5m and a robust adjusted EBITDA margin of c.34% (FY22: 34%). With good visibility on recurring revenue, a refinancing completed (and facility increased), and a likely UK general election, 2024 is shaping-up to be another year of growth. There is much cash available to continue with acquisitions, so need to avoid any missteps and overpaying. There is also a fair few local elections scheduled, on the usual rota - | strollingmolby | |
09/8/2023 16:16 | Just has the usual check from te county council for voting, only this time I did it online via an Idox product. At the end of which was a survey, which because it was Idox I completed (depsite no longer a shareholder). Efficient experience. | trcml | |
12/6/2023 09:07 | Idox (IDOX) Interim results 2023 presentation - June 23 Idox CEO, David Meaden and CFO, Anoop Kang, present interim results for the six months ended 30th April 2023, followed by Q&A. It’s a good first-half performance, with encouraging organic growth and continued cash generation. Watch the video here: Or listen to the podcast here: | tomps2 | |
26/5/2023 08:15 | It has been a long time since I invested in this but it seems to me that with the improved cash situation and contract like in post 3376 it looks a good time to revisit and review the potential once again. | clocktower | |
26/5/2023 07:52 | Idox is Proud to Announce Selection as Electoral Management System Supplier to Three New Unitary Authorities Cumberland Council, Westmorland and Furness Council, and Somerset Council have each appointed Idox as their selected Electoral Management System (EMS) supplier. Idox, a leading supplier of electoral management systems, is pleased to announce it has been chosen as the EMS supplier to three newly formed unitary authorities in the UK – Cumberland Council, Westmorland and Furness Council, and Somerset Council. The new authorities, each formed from several former districts or boroughs that had used a full range of operational EMS solutions, based their selection on hands-on experience of all the working systems available on the market. Idox’s EMS stood out from the rest, demonstrating its reliability, accuracy, and efficiency in electoral processes. At Idox, we understand the importance of providing solutions that meet the needs of electoral administrators while ensuring reliability and are committed to delivering innovative products and services that add value to our clients. We are excited to build strong, long-lasting relationships with the newly formed unitary authorities with the confidence that our EMS ecosystem of products will provide the best solutions for their electoral processes. The three new customers are currently in the migration process and are expected to go live in the next few weeks. They will benefit from all the core changes for the Elections Act 2022 that have already been deployed to our customers, and they will benefit from further changes coming down the line based on policy that is still being developed by DLUHC as we continue to collaborate with the UK Government and devolved administrations. We look forward to working closely with the newly formed unitary authorities, providing them with the support and solutions they need to ensure their electoral processes run smoothly and efficiently. | strollingmolby | |
28/4/2023 09:53 | Very quiet here- thoughts re D&D returning for another crack? Or a different suitor? | se81 | |
27/1/2023 11:12 | Idox (IDOX) full year 2022 results presentation – January 2023 Idox Chief Executive, David Meaden and CFO, Anoop Kang, present the results for the year ended 31 October 2022. “A solid performance, with strong recurring revenue and margin expansion” Watch the video here: or listen to the podcast here: | tomps2 | |
26/1/2023 16:41 | Worth watching today's results webinar imo. Management confident of hitting a 10% increase in evenue and 35% operating margin in the current FY. Definitely feels to me like we're in the 'fly' phase now, as management has been saying for a year or so. | gargoyle2 | |
03/10/2022 06:45 | Loss making tiddler | phillis | |
28/7/2022 12:10 | Chart looks like it might be turning here imo -- someone accumulating the last few weeks imo | gargoyle2 | |
15/7/2022 10:55 | ..from last month... IDOX Plc e Brief Analysis: P/E = 22.1x, below the sector threshold. P/B = 4.22x, higher than information technology threshold P/FCF = 72.6x, above information technology benchmark. EV/BITDA = 15.27, capturing intrinsic value. EPS growth = 26.7%. Operating margin of 13%... ...from WealthOracleAM | km18 | |
25/6/2022 07:59 | The base business is ex growth isn’t it | phillis | |
23/6/2022 08:34 | I wonder if the recent grant of share options exercisable at £1.20 is a stunt designed to deter existing shareholders from selling and encourage new investors o buy by thinking the share price would at least reach that level. In the recent results, CEO mentions acquisition opportunities which rather implies that without add-ons the potential for organic growth such as it is is limited. | trcml | |
22/6/2022 17:09 | Paul Scott's recent view worth a read. I'm a holder, so finding the share price decline frustrating. A good business, but the only people benefitting are the management: "Outlook is fine, with “good revenue visibility for the remainder of FY22”, and trading in line with expectations. CFO review - You have to travel quite a long way down the results statement before you find the most interesting numbers. For example, continuing revenue growth is 7%, but this includes the effect of acquisitions. The CFO review, much further down the statement, lets us know that “On a 'like for like' basis the Group delivered £30.0m of revenue, slightly down on the prior period.” So there is no organic revenue growth to speak of, only growth by acquisition. Also, why is PBT down 1% despite “adjusted EBITDA” rising 8%? The main reason is nearly £500k in additional share option costs from the company’s LTIP. My view – I’m less enthused by this one than I was before. The only thing I can see in its favour is the sticky public sector contracts. I note that the company paid out £1.8 million in total to shareholders for last year’s performance, while the LTIP has cost the company £1.25 million in just six months." I'm sure Meadon and Grubb, who hold very few shares between them, will continue to do very well for themselves. | gargoyle2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions